Fukui, Japan

Yoshimitsu Hamano

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Fukui Prefectural University, Jnc Corporation. Active years: 2011-2015.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yoshimitsu Hamano

Introduction

Yoshimitsu Hamano is a notable inventor based in Fukui, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of methods and enzymes that enhance the production of useful substances.

Latest Patents

Hamano holds two patents that showcase his innovative work. The first patent is titled "Method for producing useful substances by a recombinant actinomycete, streptomyces species." This invention provides a promoter derived from the genome of an actinomycete species, which can specifically induce expression of a transgene in an actinomycete species during and after the logarithmic growth phase. The second patent is for a "Lactam ring-opening enzyme and use thereof." This enzyme is capable of reducing the antibiotic activity of streptothricin with respect to eukaryotic cells while retaining its antibiotic activity against prokaryotic cells.

Career Highlights

Throughout his career, Yoshimitsu Hamano has worked with reputable organizations such as JNC Corporation and Fukui Prefectural University. His work in these institutions has allowed him to further his research and development in biotechnology.

Collaborations

Hamano has collaborated with notable colleagues, including Kazuya Yamanaka and Tomohiro Yoshimura. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yoshimitsu Hamano's innovative work in biotechnology has led to significant advancements in the production of useful substances and the development of enzymes with reduced toxicity. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…